Literature DB >> 11270327

Stereoselectivity of the folate transporter in rabbit small intestine: studies with amethopterin enantiomers.

T Itoh1, K Ono, K I Koido, Y H Li, H Yamada.   

Abstract

Stereoselectivity of the folate transporter was examined using rabbit intestinal brush border membrane vesicles (BBMV). Methotrexate (MTX) and the antipode (D-amethopterin) were used as model substrates of the transporter. Folic acid (FA) and MTX were actively taken up into BBMV in the presence of an H+ gradient. Initial uptake of FA and MTX was concentration-dependent with Km values of 1.5 and 1.6 microM for FA and MTX, respectively. FA and MTX mutually inhibited uptake in a competitive manner, with Ki values being similar to the corresponding Km values, demonstrating that FA and MTX share the folate transporter. D-Amethopterin also inhibited FA uptake competitively, with a Ki value approximately 60-fold greater than that of MTX, showing that the affinity of the D-isomer (D-amethopterin) to the folate transporter is much less than that of the L-isomer (MTX). The extent of stereoselectivity observed in the present study is consistent with the previously reported differences in plasma concentration between amethopterin enantiomers following oral administration in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11270327     DOI: 10.1002/1520-636X(2001)13:3<164::AID-CHIR1015>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  2 in total

1.  Comparative pharmacodynamic and pharmacokinetic study of MIDD0301 and its (S) enantiomer.

Authors:  M S Rashid Roni; Nicolas M Zahn; Gene T Yocum; Daniel A Webb; Md Yeunus Mian; Michelle J Meyer; Anika S Tylek; James M Cook; Charles W Emala; Douglas C Stafford; Leggy A Arnold
Journal:  Drug Dev Res       Date:  2022-03-04       Impact factor: 5.004

2.  Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells.

Authors:  Viral Kansara; Durga Paturi; Shuanghui Luo; Ripal Gaudana; Ashim K Mitra
Journal:  Int J Pharm       Date:  2007-12-23       Impact factor: 5.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.